Literature DB >> 17108050

GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1.

Norihiro Takenouchi1, Kathryn S Jones, Ivonne Lisinski, Kazunori Fugo, Karen Yao, Samuel W Cushman, Francis W Ruscetti, Steven Jacobson.   

Abstract

GLUT1 has recently been suggested to be a binding receptor for human T-cell leukemia virus type 1 (HTLV-1). We used a novel, short-term assay to define the role of GLUT1 in cell-to-cell transmission. Although increasing cell surface levels of GLUT1 enhanced HTLV-I transfer, efficient virus spread correlated largely with heparan sulfate proteoglycan (HSPG) expression on target cells. Moreover, since activated CD4+ T cells and cord blood lymphocytes that are susceptible to HTLV-1 infection expressed undetectable levels of surface GLUT1, these results indicate that GLUT1 and HSPGs are important for efficient cell-to-cell transmission of HTLV-1 but raise concerns on the role of GLUT1 as the HTLV-1 primary binding receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108050      PMCID: PMC1797527          DOI: 10.1128/JVI.01522-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Overexpression of the glucose transporter GLUT4 in adipose cells interferes with insulin-stimulated translocation.

Authors:  H Al-Hasani; D R Yver; S W Cushman
Journal:  FEBS Lett       Date:  1999-10-29       Impact factor: 4.124

2.  Targeting of GLUT6 (formerly GLUT9) and GLUT8 in rat adipose cells.

Authors:  I Lisinski; A Schürmann; H G Joost; S W Cushman; H Al-Hasani
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

3.  The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV.

Authors:  Nicolas Manel; Felix J Kim; Sandrina Kinet; Naomi Taylor; Marc Sitbon; Jean-Luc Battini
Journal:  Cell       Date:  2003-11-14       Impact factor: 41.582

4.  Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation.

Authors:  Manisha D Nath; Francis W Ruscetti; Cari Petrow-Sadowski; Kathryn S Jones
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

5.  Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).

Authors:  Yoshihisa Yamano; Masahiro Nagai; Meghan Brennan; Carlos A Mora; Samantha S Soldan; Utano Tomaru; Norihiro Takenouchi; Shuji Izumo; Mitsuhiro Osame; Steven Jacobson
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

6.  Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.

Authors:  Kathryn S Jones; Kazunori Fugo; Cari Petrow-Sadowski; Ying Huang; Daniel C Bertolette; Ivonne Lisinski; Samuel W Cushman; Steven Jacobson; Francis W Ruscetti
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions.

Authors:  Kathryn S Jones; Manisha Nath; Cari Petrow-Sadowski; Andrea C Baines; Megan Dambach; Ying Huang; Francis W Ruscetti
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.

Authors:  Tadahiko Igakura; Jane C Stinchcombe; Peter K C Goon; Graham P Taylor; Jonathan N Weber; Gillian M Griffiths; Yuetsu Tanaka; Mitsuhiro Osame; Charles R M Bangham
Journal:  Science       Date:  2003-02-13       Impact factor: 47.728

9.  Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.

Authors:  Josefina D Piñon; P J Klasse; Sushma R Jassal; Sandy Welson; Jonathan Weber; David W Brighty; Quentin J Sattentau
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis.

Authors:  Nicolas Manel; Sandrina Kinet; Jean-Luc Battini; Felix J Kim; Naomi Taylor; Marc Sitbon
Journal:  Blood       Date:  2002-10-17       Impact factor: 22.113

View more
  25 in total

1.  Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection.

Authors:  Clovis S Palmer; Matias Ostrowski; Maelenn Gouillou; Louis Tsai; Di Yu; Jingling Zhou; Darren C Henstridge; Anna Maisa; Anna C Hearps; Sharon R Lewin; Alan Landay; Anthony Jaworowski; Joseph M McCune; Suzanne M Crowe
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

Review 2.  T cell metabolism in chronic viral infection.

Authors:  L J Pallett; N Schmidt; A Schurich
Journal:  Clin Exp Immunol       Date:  2019-05-20       Impact factor: 4.330

3.  Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.

Authors:  Yosuke Maeda; Hiromi Terasawa; Yuetsu Tanaka; Chisho Mitsuura; Kaori Nakashima; Keisuke Yusa; Shinji Harada
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

4.  Dynamic acquisition of HTLV-1 tax protein by mononuclear phagocytes: Role in neurologic disease.

Authors:  Eiji Matsuura; Yoshimi Enose-Akahata; Karen Yao; Unsong Oh; Yuetsu Tanaka; Hiroshi Takashima; Steven Jacobson
Journal:  J Neuroimmunol       Date:  2016-10-03       Impact factor: 3.478

5.  HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.

Authors:  Sophie Lambert; Manuella Bouttier; Roger Vassy; Michel Seigneuret; Cari Petrow-Sadowski; Sébastien Janvier; Nikolaus Heveker; Francis W Ruscetti; Gérard Perret; Kathryn S Jones; Claudine Pique
Journal:  Blood       Date:  2009-03-06       Impact factor: 22.113

6.  The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.

Authors:  Kathryn S Jones; Ying K Huang; Sébastien A Chevalier; Philippe V Afonso; Cari Petrow-Sadowski; Daniel C Bertolette; Antoine Gessain; Francis W Ruscetti; Renaud Mahieux
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

7.  DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.

Authors:  Pooja Jain; Sharrón L Manuel; Zafar K Khan; Jaya Ahuja; Kevin Quann; Brian Wigdahl
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

8.  Effect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro.

Authors:  Emanuela Balestrieri; Claudia Matteucci; Arianna Ascolani; Anna Piperno; Roberto Romeo; Giovanni Romeo; Ugo Chiacchio; Antonio Mastino; Beatrice Macchi
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

9.  Inhibition of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro by carbohydrate-binding agents.

Authors:  Emanuela Balestrieri; Arianna Ascolani; Yasuhiro Igarashi; Toshikazu Oki; Antonio Mastino; Jan Balzarini; Beatrice Macchi
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

Review 10.  Mechanisms of HTLV-1 persistence and transformation.

Authors:  M Boxus; L Willems
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.